These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 26328427)
1. Preparation and Biophysical Characterization of Poly(amidoamine) Dendrimer-Poly(acrylic acid) Graft. Dung TH; Do le T; Loan TT; Yoo H J Nanosci Nanotechnol; 2015 Jan; 15(1):684-7. PubMed ID: 26328427 [TBL] [Abstract][Full Text] [Related]
2. Preparation and biophysical characterization of pluronic F127-dendrimer conjugate as a delivery agent of antisense oligonucleotides. Dung TH; Kim J; Kim MS; Kim JS; Yoo H J Nanosci Nanotechnol; 2008 Oct; 8(10):5326-30. PubMed ID: 19198448 [TBL] [Abstract][Full Text] [Related]
3. Polypropyleneimine and polyamidoamine dendrimer mediated enhanced solubilization of bortezomib: Comparison and evaluation of mechanistic aspects by thermodynamics and molecular simulations. Chaudhary S; Gothwal A; Khan I; Srivastava S; Malik R; Gupta U Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():611-619. PubMed ID: 28024628 [TBL] [Abstract][Full Text] [Related]
4. Poly(amidoamine) dendrimers grafted on electrospun poly(acrylic acid)/poly(vinyl alcohol) membranes for host-guest encapsulation of antioxidant thymol. Amariei G; Boltes K; Letón P; Iriepa I; Moraleda I; Rosal R J Mater Chem B; 2017 Sep; 5(33):6776-6785. PubMed ID: 32264327 [TBL] [Abstract][Full Text] [Related]
6. G5-PEG PAMAM dendrimer incorporating nanostructured lipid carriers enhance oral bioavailability and plasma lipid-lowering effect of probucol. Qi R; Li YZ; Chen C; Cao YN; Yu MM; Xu L; He B; Jie X; Shen WW; Wang YN; van Dongen MA; Liu GQ; Banaszak Holl MM; Zhang Q; Ke X J Control Release; 2015 Jul; 210():160-8. PubMed ID: 26003044 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and characterization of G5 PAMAM dendrimer containing daunorubicin for targeting cancer cells. Yue Y; Eun JS; Lee MK; Seo SY Arch Pharm Res; 2012 Feb; 35(2):343-9. PubMed ID: 22370789 [TBL] [Abstract][Full Text] [Related]
8. Low systemic toxicity nanocarriers fabricated from heparin-mPEG and PAMAM dendrimers for controlled drug release. Thanh VM; Nguyen TH; Tran TV; Ngoc UP; Ho MN; Nguyen TT; Chau YNT; Le VT; Tran NQ; Nguyen CK; Nguyen DH Mater Sci Eng C Mater Biol Appl; 2018 Jan; 82():291-298. PubMed ID: 29025661 [TBL] [Abstract][Full Text] [Related]
9. Tailor-made pH-sensitive polyacrylic acid functionalized mesoporous silica nanoparticles for efficient and controlled delivery of anti-cancer drug Etoposide. Saroj S; Rajput SJ Drug Dev Ind Pharm; 2018 Jul; 44(7):1198-1211. PubMed ID: 29412022 [TBL] [Abstract][Full Text] [Related]
10. Molecular heterogeneity analysis of poly(amidoamine) dendrimer-based mono- and multifunctional nanodevices by capillary electrophoresis. Shi X; Majoros IJ; Patri AK; Bi X; Islam MT; Desai A; Ganser TR; Baker JR Analyst; 2006 Mar; 131(3):374-81. PubMed ID: 16496045 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and characterization of pH-responsive and fluorescent poly (amidoamine) dendrimer-grafted cellulose nanocrystals. Chen L; Cao W; Grishkewich N; Berry RM; Tam KC J Colloid Interface Sci; 2015 Jul; 450():101-108. PubMed ID: 25801138 [TBL] [Abstract][Full Text] [Related]
12. Carboxymethyl chitosan-poly(amidoamine) dendrimer core-shell nanoparticles for intracellular lysozyme delivery. Zhang X; Zhao J; Wen Y; Zhu C; Yang J; Yao F Carbohydr Polym; 2013 Nov; 98(2):1326-34. PubMed ID: 24053810 [TBL] [Abstract][Full Text] [Related]
13. Multifunctional lactobionic acid-modified dendrimers for targeted drug delivery to liver cancer cells: investigating the role played by PEG spacer. Fu F; Wu Y; Zhu J; Wen S; Shen M; Shi X ACS Appl Mater Interfaces; 2014 Sep; 6(18):16416-25. PubMed ID: 25185074 [TBL] [Abstract][Full Text] [Related]
14. Impact of dendrimer surface functional groups on the release of doxorubicin from dendrimer carriers. Zhang M; Guo R; Kéri M; Bányai I; Zheng Y; Cao M; Cao X; Shi X J Phys Chem B; 2014 Feb; 118(6):1696-706. PubMed ID: 24467521 [TBL] [Abstract][Full Text] [Related]
15. Physicochemical and biological properties of self-assembled antisense/poly(amidoamine) dendrimer nanoparticles: the effect of dendrimer generation and charge ratio. Nomani A; Haririan I; Rahimnia R; Fouladdel S; Gazori T; Dinarvand R; Omidi Y; Azizi E Int J Nanomedicine; 2010 May; 5():359-69. PubMed ID: 20517481 [TBL] [Abstract][Full Text] [Related]
16. PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality. Majoros IJ; Myc A; Thomas T; Mehta CB; Baker JR Biomacromolecules; 2006 Feb; 7(2):572-9. PubMed ID: 16471932 [TBL] [Abstract][Full Text] [Related]
17. Preparation and in vitro characterization of pluronic-attached polyamidoamine dendrimers for drug delivery. Gu Z; Wang M; Fang Q; Zheng H; Wu F; Lin D; Xu Y; Jin Y Drug Dev Ind Pharm; 2015 May; 41(5):812-8. PubMed ID: 24745851 [TBL] [Abstract][Full Text] [Related]
18. Poly (amidoamine) dendrimer-mediated hybrid formulation for combination therapy of ramipril and hydrochlorothiazide. Singh MK; Pooja D; Kulhari H; Jain SK; Sistla R; Chauhan AS Eur J Pharm Sci; 2017 Jan; 96():84-92. PubMed ID: 27614111 [TBL] [Abstract][Full Text] [Related]
19. Novel water-soluble and pH-responsive anticancer drug nanocarriers: doxorubicin-PAMAM dendrimer conjugates attached to superparamagnetic iron oxide nanoparticles (IONPs). Chang Y; Meng X; Zhao Y; Li K; Zhao B; Zhu M; Li Y; Chen X; Wang J J Colloid Interface Sci; 2011 Nov; 363(1):403-9. PubMed ID: 21821262 [TBL] [Abstract][Full Text] [Related]
20. Interaction between PAMAM-NH₂ G4 dendrimer and 5-fluorouracil in aqueous solution. Buczkowski A; Sekowski S; Grala A; Palecz D; Milowska K; Urbaniak P; Gabryelak T; Piekarski H; Palecz B Int J Pharm; 2011 Apr; 408(1-2):266-70. PubMed ID: 21335079 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]